J8999 HCPCS Level II code: Prescription drug, oral, chemotherapeutic, nos
J8999 is the HCPCS code for “Prescription drug, oral, chemotherapeutic, nos” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J8999Prescription drug, oral, chemotherapeutic, nos
Short description: Oral prescription drug chemo
HCPCS · United States
Medicare details
The indicators CMS publishes with J8999 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1995
Where J8999 sits
- 1J codesDrugs administered other than orally
- 2Active code J8999Prescription drug, oral, chemotherapeutic, nos
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J8999 mean?
J8999 is the HCPCS code for “Prescription drug, oral, chemotherapeutic, nos” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J8999?
CMS lists J8999’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J8999
All J codesJ8612Methotrexate (xatmep), oral, 2.5 mgJ8650Nabilone, oral, 1 mgJ8655Netupitant 300 mg and palonosetron 0.5 mg, oralJ8670Rolapitant, oral, 1 mgJ8700Temozolomide, oral, 5 mgJ8705Topotecan, oral, 0.25 mgJ9000Injection, doxorubicin hydrochloride, 10 mgJ9003Leuprolide injectable (camcevi etm), 1 mgJ9010Injection, alemtuzumab, 10 mgJ9011Injection, datopotamab deruxtecan-dlnk, 1 mgJ9015Injection, aldesleukin, per single use vialJ9017Injection, arsenic trioxide, 1 mg